Meng-Chao Wu
- Hepatology top 1%
- Molecular Biology top 10%
- Oncology top 5%
- Epidemiology top 5%
- Surgery top 10%
- Co-authors
- Xia Sui-shengWan Yee LauZe‐Ya PanHongyang WangWen‐Ming CongBaihe ZhangEric C. H. LaiWeiping Zhou
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (27 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers)Liver Disease Diagnosis and Treatment (12 papers)
- Cited by
- HepatologyCancer ResearchOncology
- Journals
- PLoS ONEHepatologyAnnals of Surgery
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Meng-Chao Wu
80 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 105
- Hepatology 777
- Molecular Biology 704
- Oncology 575
- Epidemiology 511
- Surgery 497
Countries citing papers authored by Meng-Chao Wu
This map shows the geographic impact of Meng-Chao Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng-Chao Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng-Chao Wu more than expected).
Fields of papers citing papers by Meng-Chao Wu
This network shows the impact of papers produced by Meng-Chao Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng-Chao Wu. The network helps show where Meng-Chao Wu may publish in the future.
Co-authorship network of co-authors of Meng-Chao Wu
This figure shows the co-authorship network connecting the top 25 collaborators of Meng-Chao Wu. A scholar is included among the top collaborators of Meng-Chao Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng-Chao Wu. Meng-Chao Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 184 | |
| 2 | 1 | |
| 3 | 10 | |
| 4 | 65 | |
| 5 | 128 | |
| 6 | 1 | |
| 7 | 132 | |
| 8 | 4 | |
| 9 | 12 | |
| 10 | An anti-preS2 antibody protects human hepatocytes from hepatitis B virus infection. | 2 |
| 11 | 5 | |
| 12 | 12 | |
| 13 | 32 | |
| 14 | 13 | |
| 15 | 47 | |
| 16 | 0 | |
| 17 | 13 | |
| 18 | 1 | |
| 19 | [The effect of postoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma]. | 1 |
| 20 | Treatment of Murine Allergic Contact Dermatitis with CTLA4-Ig | 1 |
About Meng-Chao Wu
Meng-Chao Wu is a scholar working on Hepatology, Cancer Research and Oncology, having authored 81 papers that have together received 2.1k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (27 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers) and Liver Disease Diagnosis and Treatment (12 papers). The work is most often cited by research in Hepatology (777 citations), Cancer Research (462 citations) and Oncology (575 citations). Meng-Chao Wu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xia Sui-sheng, Wan Yee Lau, Ze‐Ya Pan, Hongyang Wang, Wen‐Ming Cong, Baihe Zhang, Eric C. H. Lai, Weiping Zhou, Siyuan Fu and Aijun Li. Their work appears in journals such as PLoS ONE, Hepatology and Annals of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.